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Abstract: Leishmaniases are neglected infectious diseases caused by parasites of the ‘protozoan’
genus Leishmania. Depending on the parasite species, different clinical forms are known as
cutaneous, muco-cutaneous, and the visceral leishmaniasis (VL). VL is particularly fatal and
the therapy presents limitations. In the search for new anti-leishmanial hit compounds, seven
natural sesquiterpene lactones were evaluated against promastigotes and intracellular amastigotes
of Leishmania (Leishmania) infantum, a pathogen causing VL. The pseudoguaianolides mexicanin
I and helenalin acetate demonstrated the highest selectivity and potency against intracellular
amastigotes. In addition, promastigotes treated with helenalin acetate were subject to an
ultrastructural and biochemical investigation. The lethal action of the compound was investigated
by fluorescence-activated cell sorting and related techniques to detect alterations in reactive oxygen
species (ROS) content, plasma membrane permeability, and mitochondrial membrane potential.
Helenalin acetate significantly reduced the mitochondrial membrane potential and the mitochondrial
structural damage was also confirmed by transmission electron microscopy, displaying an intense
organelle swelling. No alteration of plasma membrane permeability or ROS content could be
detected. Additionally, helenalin acetate significantly increased the production of nitric oxide in
peritoneal macrophages, probably potentiating the activity against the intracellular amastigotes.
Helenalin acetate could hence be a useful anti-leishmanial scaffold for further optimization studies.
Keywords: sesquiterpene lactones; pseudoguaianolides; helenalin acetate; mexicanin I;
Leishmania (L.) infantum; drugs; nitric oxide
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1. Introduction
Leishmaniases are listed as neglected tropical diseases by the World Health Organization [1].
Nowadays, these diseases affect 98 countries. In Brazil, an increased number of cases has been observed
in recent years, accompanied by a geographical spread [1]. Worldwide, an estimated 1.3 million new
cases and 20,000–30,000 deaths are reported annually; around 310 million people are at risk of an
infection [1].
Depending on the parasite species and determinants of susceptibility of the vertebrate hosts,
Leishmania infections present different clinical forms: cutaneous, mucocutaneous, and visceral
leishmaniasis (VL) [2,3]. Untreated VL accounts for the majority of deaths reported for the
leishmaniases [1]. In VL, the parasites affect mainly the spleen, liver, and bone marrow, where they
multiply inside macrophages, causing organ hypertrophy (hepatosplenomegaly) and dysfunction [4].
Besides the high prevalence, impact, and risk among the world population, existing treatments for VL
exhibit strong limitations, including high toxicity leading to severe adverse effects, high costs, parasite
resistance, and hospitalization due to parenteral administration [5,6]. Therefore, new therapies for this
disease are desirable.
Natural products traditionally play an important role in search for new therapeutics. Their large
structural diversity of secondary metabolites is a source of novel chemical structures as starting
points for drug development [7–11]. Natural sesquiterpene lactones (STLs) are widespread secondary
metabolites in plants of the family Asteraceae [12]. This class of compounds are known for a wide
range of biological activities such as anticancer [13,14], gastric cytoprotective [15] but also cytotoxic [16]
effects, and in vitro anti-trypanosomatid activities [17–23].
In this work, we evaluated the in vitro activity of the pseudoguaianolides mexicanin I
and helenalin acetate; the guaianolides arglabin and cynaropicrin; eudesmanolide alantolactone;
germacranolide parthenolide; and furanoheliangolide budlein A (Figure 1) against promastigotes and
intracellular amastigotes of Leishmania (Leishmania) infantum, the etiologic agent of VL in wide parts of
South America and the Mediterranean region. Using different techniques, we studied the mechanism
of action of the most active and selective STL in L. (L.) infantum, evaluating different parameters
of the parasite such as plasma membrane permeability, reactive oxygen species (ROS) content, and
mitochondrial membrane potential (∆ψm) as well as the production of nitric oxide (NO) by host cells.
2. Results and Discussion
Anti-L. (L.) infantum Activity of STL
Seven representative STLs (Figure 1) were chosen for this study since they had demonstrated
different levels of in vitro anti-trypanosomatid activity against Trypanosoma brucei rhodesiense and
Leishmania donovani (axenic amastigotes) in previous studies [22,23]. Their activity against L. (L.)
infantum as well as their cytotoxicity and selectivity is demonstrated in Table 1. All compounds
displayed in vitro activity against L. (L.) infantum promastigotes, with IC50 values in a concentration
range between 3 and 59 µM. The pseudoguaianolides helenalin acetate (1) and mexicanin I (2)
showed the most potent activity against the intracellular amastigotes and highest selectivity indices
(S.I. = IC50(cytotox.)/IC50(amastigote)), with IC50 values of 1.15 µM (S.I. 7) and 1.73 µM (S.I. 5.3),
respectively. Argablin (3) and cynaropicrin (4) also demonstrated selectivity against the intracellular
amastigotes, but were about 6-fold less effective than the compounds 1 and 2, demonstrating
IC50 values of 7.33 (S.I. 5.3) and 6.88 µM (S.I. 4.8), respectively. Compounds 1 and 2 were about
15-fold more effective than miltefosine, the standard drug used to treat VL. Effects of 1 on intracellular
amastigotes as observed by light microscopy are shown in Figure S1, Supplementary Material.
The unesterified parent compound of 1, helenalin, and 2 were previously shown to have
activity against L. (L.) mexicana at low concentrations, one of the species responsible for cutaneous
leishmaniasis [20]. Considering the selectivity index and the high potency against promastigotes and
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intracellular amastigotes, compound 1 was selected for further studies aiming at biochemical and
ultrastructural investigations in L. (L.) infantum parasites after treatment.Molecules 2017, 22, 685 3 of 12 
 
 
Figure 1. Structures of the tested sesquiterpene lactones (STLs). (1) Helenalin acetate; (2) Mexicanin I; 
(3) Arglabin; (4) Cynaropicrin; (5) Alantolactone; (6) Parthenolide; (7) Budlein A. 
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Helenalin acetate (1) 3.53 (0.2) 1.15 (0.22) 8.12 (1.47) 7.0 
Mexicanin I (2) 4.89 (1.2) 1.73 (0.7) 9.20 (2.74) 5.3 
Arglabin (3) 29.98 (2.4) 7.33 (4.0) 39.35 (6.38) 5.3 
Cynaropicrin (4) 30.59 (0.61) 6.88 (3.5) 33.54 (7.39) 4.8 
Alantolactone (5) 9.94 (0.14) n.a. 11.04 (1.61) - 
Parthenolide (6) 59.13 (4.00) 89.20 (-) 58.18 (9.14) <1 
Budlein A (7) 28.00 (7.87) n.a. 9.05 (1.86) - 
Miltefosine 16.69 (3.49) 17.80 (1.39) 116.70 (5.30) 6.5 
IC50: 50% inhibitory concentration; CC50: 50% cytotoxic concentration; n.a.: not active to the highest 
concentration of 100 μM; SI: selectivity index based on CC50 in murine fibroblasts (NCTC)/IC50 in 
amastigotes. 
The parasite’s plasma membrane regulates the transport of nutrients, pH homeostasis, and 
homeostasis of other ions [24]. Thus, we investigated the effect of 1 on the parasite plasma membrane 
using the probe SYTOX Green. This probe shows fluorescence when it gets in contact with nucleic 
acids, reaching the intracellular milieu via a severely damaged plasma membrane [25]. No significant 
increase of SYTOX Green fluorescence could be detected after treatment with compound 1 (3 and 6 μM) 
Figure 1. Structures of the tested sesquiterpene lactones (STLs). (1) Helenalin acetate; (2) Mexicanin I;
(3) Arglabin; (4) Cynaropicrin; (5) Alantolactone; (6) Parthenolide; (7) Budlein A.
Table 1. In vitro antileishmanial activity and mammalian cytotoxicity of sesquiterpene lactones (STLs).
o pounds
L. (L.) i f tu
Pro ti tes
L. (L.) i f tu
A ti tes Cytotoxicity SI
(NCTC/Amastigote)
IC50 (µM) (SD) IC50 (µM) (SD) C 50 (µM) (SD)
Helenalin acetate (1) 3.53 (0.2) 1.15 (0.22) 8.12 (1.47) 7.0
Mexicanin I (2) 4.89 (1.2) 1.73 (0.7) 9.20 (2.74) 5.3
Arglabin (3) 29.98 (2.4) 7.33 (4.0) 39.35 (6.38) 5.3
Cynaropicrin (4) 30.59 (0.61) 6.88 (3.5) 33. 4 (7.39) 4.8
Ala tolactone 5 9.94 (0.14) n.a. 11.04 (1.61) -
Parthenolide (6) 59.13 (4.00) 89.20 (-) 58.18 (9. 4) <1
Budlein A (7) 28.00 (7.87) n.a. 9.05 (1.86) -
Miltefosine 16.69 (3.49) 17.80 (1.39) 116.70 (5.30) 6.5
IC50: 50% inhibitory concentration; CC50: 50% cytotoxic concentration; n.a.: not active to the highest concentration
of 100 µM; SI: selectivity index based on CC50 in murine fibroblasts (NCTC)/IC50 in amastigotes.
The parasite’s plasma membrane regulates the transport of nutrients, pH homeostasis, and
homeostasis of other ions [24]. Thus, we investigated the effect of 1 on the parasite plasma membrane
using the robe SYTOX Green. This probe shows fluorescence when it gets in contact with nucleic
acids, reaching the intracellular milieu via a severely damaged plasma membrane [25]. No significa t
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increase of SYTOX Green fluorescence could be detected after treatment with compound 1 (3 and 6 µM)
during 60 min (Figure 2), in comparison with untreated parasites. Thus, it can be concluded that 1 has
no influence on the plasma membrane permeability of the parasite.
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Figure 2. Permeability of L. (L.) infantum plasma membrane incubated with compound 1 assessed 
spectrofluorimetrically by the fluorescence of the SYTOX Green. Promastigotes were treated with 1  
(3 and 6 μM) for 60 min. At the end of this treatment, Triton X-100 was used for 100% permeabilization. 
Dimethyl sulfoxide (DMSO) was used as internal control and did not cause any alteration in membrane 
permeability (data not shown). 
It is known that vital processes of Leishmania promastigotes are irreversibly affected by helenalin 
at short periods of exposure (3 h) [20]. Having ruled out the plasma membrane as target, the next step 
was the investigation of a possible influence of helenalin acetate (1) on the mitochondria of  
L. (L.) infantum promastigotes, a recognized target for a number of antileishmanial compounds [26]. 
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proportional to the redox state of the parasite. In contrast to oligomycin (20 μM), a mitochondrial 
respiratory chain inhibitor of the ATP synthase (complex V), which increased the ROS production 
over time, promastigotes treated with 1 showed no alteration of ROS after 1 h of treatment (Figure 3b). 
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Figure 2. Permeability of L. (L.) infantum plasma membrane incubated with compound 1 assessed
spectrofluorimetrically by the fluorescence of the SYTOX Green. Promastigotes were treated with 1
(3 and 6 µM) for 60 min. At the end of this treatment, Triton X-100 was used for 100% permeabilization.
Dimethyl sulfoxide (DMSO) was used as internal control and did not cause any alteration in membrane
permeability (data not shown).
It is known that vital processes of Leishmania promastigotes are irreversibly affected by helenalin at
short periods of exposure (3 h) [20]. Having ruled out the plasma membrane as target, the next step was
the investigation of a possible influence of helenalin acetate (1) on the mitochondria of L. (L.) infantum
promastigotes, a recognized target for a number of antileishmanial compounds [26]. Leishmania is
known to have a single mitochondrion as major supplier of cellular energy—i.e., ATP—through the
metabolism of the respiratory chain [27]. The mitochondrial membrane potential (∆ψm) is a crucial
component in ATP production and its maintenance is essential for the parasite survival. Therefore,
disturbances in the ∆ψm of L. (L.) infantum promastigotes treated with 1 were investigated using
the fluorescent probe rhodamine 123. Rhodamine 123 (Rd123) is a fluorescent cationic dye that
accumulates into polarized mitochondria. Depolarization, i.e., a decrease in ∆ψm, results in a lower
accumulation of rhodamine and, consequently, in a reduced fluorescence [28]. Parasites treated
for 1 h with compound 1 at a concentration representing the previously determined IC99 value
(6 µM), decreased the fluorescence of Rd123 by 60% in comparison to untreated parasites (Figure 3a).
This effect on the ∆ψm was similar to that obtained with 10 µM carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP), a known mitochondrial uncoupler. A previous study with parthenolide (6)
against axenic amastigotes (extracellular) of L. (L.) amazonensis, also demonstrated a mitochondrial
depolarization with this sesquiterpene lactone [21]. The exact mechanism by which 1 or 6 affect the
∆ψm of Leishmania remains to be elucidated.
Derangements in ∆ψm are usually linked to overproduction of ROS, resulting in mitochondrial
dysfunction and ultimately cell death [29,30]. Accordingly, the production of ROS in promastigotes
treated with compound 1 was determined using the dye 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCFDA) and flow cytometry. The fluorescence intensity of this dye has been assumed to be
proportional to the redox state of the parasite. In contrast to oligomycin (20 µM), a mitochondrial
respiratory chain inhibitor of the ATP synthase (complex V), which increased the ROS production over
time, promastigotes treated with 1 showed no alteration of ROS after 1 h of treatment (Figure 3b).
Molecules 2017, 22, 685 5 of 12
The impairment in ∆ψm accompanied by ROS generation is commonly described for STLs in
cancer cell lines [31,32]. It was suggested that, in these cells, STLs cause a knockdown of crucial
enzymes that participate in the redox defense metabolism, resulting in ROS accumulation [33].
Similarly, some STLs have been described to induce ROS generation concomitant with reduction
of glutathione (GSH) content in Leishmania promastigotes. GSH is an important metabolite of the redox
defense metabolism of the parasite as a precursor for the synthesis of trypanothione. It was proposed
that STLs react with sulfhydryl groups by the Michael-type addition; thus, impairment of redox defense
metabolism of parasites should not be ruled out in Leishmania [34]. However, the absence of an increase
in ROS generation in promastigotes treated with 1, even in disturbed mitochondria as indicated by
the affected ∆ψm, suggests that the redox defense metabolism was probably not affected by this STL
throughout the incubation period. Likewise, psilostachyin C—another STL—also demonstrated a
leishmanicidal effect through a lethal mechanism other than oxidative stress or reduction of GSH
content in the parasite [34]. In summary, the mitochondrial dysfunction provoked by STLs in Leishmania
may have distinct mechanisms.
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of duplicate samples. For each assay, one representative of two independently performed experiments 
is shown. n.s, not significant; *** indicates significant differences with the control at p < 0.001;  
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In addition to these biochemical investigations, an ultrastructural study using Transmission 
Electron Microscopy (TEM) was used to investigate the alterations in L. (L.) infantum promastigotes 
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ultrastructural alterations in promastigotes after 30 min of incubation, with increasing damage 
throughout the time interval studied, 4 h (Figure 4). The integrity of plasma membrane and 
pericellular microtubules was preserved over 4 h, corroborating the aforementioned SYTOX Green 
assay (Figure 4). Similarly, 1 induced no alteration of the plasma membrane of L. (L.) mexicana 
promastigotes after a long-term treatment [20]. The previously observed mitochondrial dysfunction 
could now be confirmed by a visible swelling of the organelle (Figure 4b–f, red arrows) during the 
treatment with 1. The strong vacuolization of the cytoplasm was associated with autophagic processes 
as judged by presence of multivesicular structures (Figure 4f). Autophagy can be triggered by the cell 
for energy production, cell recycling, or death signalling [35]. Detachment of the nuclear membrane 
(Figure 4e, blue arrow) was initially observed after 3 h followed by chromatin decondensation after 
4 h of incubation (Figure 4g, red arrow). Usually, this event precedes the DNA fragmentation which 
has also been reported to occur in L. (L.) mexicana promastigotes after long treatment with unesterified 
helenalin [20]. In summary, the ultrastructural analysis showed that compound 1 induced a rounded 
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In addition to these bioche ical investigations, an ultrastructural study using Trans ission
Electron icroscopy (TE ) as used to investigate the alterations in L. (L.) infantu pro astigotes
treated ith co pound 1 at 1 µM over different incubation times. 1 induced early morphological
and ultrastructural alterations in promastigotes after 30 min of incubation, with increasing da age
throughout the time interval studied, 4 h (Figure 4). The integrity of plasma membrane and pericellular
microtubules was preserved over 4 h, corroborating the aforementioned SYTOX Green assay (Figure 4).
Similarly, 1 induced no alteration of the plasma membrane of L. (L.) mexicana promastigotes after a
long-term treatment [20]. The previously observed mitochondrial dysfunction could now be confirmed
by a visible swelling of the organelle (Figure 4b–f, red arrows) during the treatment with 1. The strong
vacuolization of the cytoplasm was associated with autophagic processes as judged by presence of
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multivesicular structures (Figure 4f). Autophagy can be triggered by the cell for energy production, cell
recycling, or death signalling [35]. Detachment of the nuclear membrane (Figure 4e, blue arrow)
was initially observed after 3 h followed by chromatin decondensation after 4 h of incubation
(Figure 4g, red arrow). Usually, this event precedes the DNA fragmentation which has also been
reported to occur in L. (L.) mexicana promastigotes after long treatment with unesterified helenalin [20].
In summary, the ultrastructural analysis showed that compound 1 induced a rounded amastigote-like
morphology (compare Figure 4a with Figure 4g) with intense cytoplasmatic vacuolization, formation
of autophagosomes, swelling of the mitochondrion, and chromatin decondensation (Figure 4g).
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via macrophage activation mechanisms. Macrophages play an important role in the vertebrate 
immune system and represent the primary cells infected by Leishmania. Their activation profile is 
decisive for the resolution of the infection [36,37]. It has been demonstrated that macrophage-
mediated killing of Leishmania could be an event associated with the up-regulation of NO. After 
stimulation with lipopolysaccharide (LPS), macrophages are activated to produce NO from arginine, 
controlling the proliferation of intracellular parasites such as L. (L.) major [38]. Considering the higher 
activity of 1 against the intracellular amastigotes of L. (L.) infantum as compared to extracellular 
promastigotes (Table 1), we investigated the possibility of the host cell participating in the elimination 
of the parasites. The NO levels of peritoneal macrophages treated with 1 at 3 μM were determined after 
24 h incubation using the colorimetric Griess assay [39]. Our data demonstrated that 1 significantly 
increased the production of NO at similar levels as cells treated with LPS (positive control) (Figure 5). This 
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Figure 4. Transmission electron microscopy imaging of L. (L.) infantum promastigotes treated with
helenalin acetate (1). 2 × 107 promastigotes/well were incubated with 1 for different periods of time.
(a) Untreated control. (b) 0.5 h; (c) 1 h; (d) 2 h; (e,f) 3 h; (g) 4 h. The figure shows representative
images taken from one out of two independent experiment. The observed ultrastructural observations
appeared consistently in both independent Transmission Electron Microscopy (TEM) experiments.
Besides direct effects on the parasite, antileishmanial compounds can lso trigger a lethal ffect via
macrophage activation mecha isms. Macrophages play an important role in the ver ebrate immune
syst m and represent the primary cells infected by Leishm nia. Their activation profile is decisiv for
the resolution of the infectio [36,37]. It h s be demonstrated that mac oph ge-mediated killing
of Leishmania could be an event associated with t e up-regulation of NO. After stimulation with
lipopolysaccharide (LPS), macrophages are activated to produce NO from arginine, controlling the
proliferation of intracellular parasites such as L. (L.) major [38]. Considering the higher activity of 1
against the intracellular amastigotes of L. (L.) infantum as compared to extracellular promastigotes
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(Table 1), we investigated the possibility of the host cell participating in the elimination of the parasites.
The NO levels of peritoneal macrophages treated with 1 at 3 µM were determined after 24 h incubation
using the colorimetric Griess assay [39]. Our data demonstrated that 1 significantly increased the
production of NO at similar levels as cells treated with LPS (positive control) (Figure 5). This result
suggests that 1 elicited an immunomodulatory effect that may have contributed to reduce the infection
by L. (L.) infantum via an NO-mediated mechanism.Molecules 2017, 22, 685 7 of 12 
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3. Materials and Methods 
3.1. Compounds 
The STLs investigated in this study were previously isolated in our laboratories (T.J.S., F.B.C.) 
from plants of the family Asteraceae. Helenalin acetate (1) and mexicanin I (2) were isolated from  
A. montana L. and Arnica acaulis (Walter) Britton, Sterns and Poggenb., respectively. The guaianolides 
arglabin (3) and cynaropicrin (4) originate from Artemisia glabella Kar. Et Kir. Fl. Alt. and Cynara 
cardunculus L., respectively. Alantolactone (5) is an eudesmanolide isolated from Inula helenium L. 
The germacranolide parthenolide (6) and the furanoheliangolide budlein A (7) were isolated from 
Tanacetum parthenium (L.) Sch. Bip. and Aldama robusta (Gardner) E.E.Schill and Panero (formerly: 
Viguiera robusta). Further details on the origin of these compounds and their purity were published 
previously [18,22,23]. In all cases, stock solutions were prepared with dimethyl sulfoxide (DMSO) 
which were subsequently diluted with the respective medium to the specific concentration used in 
the various bioassays. 
3.2. Animals 
Golden hamsters (Mesocricetus auratus Waterhouse) were used for the maintenance of the L. (L.) 
infantum (MHOM/BR/1972/LD) culture. Young female BALB/c mice (Mus musculus L.) with a weight 
of 18–24 g were used as a source of peritoneal macrophages. 
Animals were provided by the animal facility of the Adolfo Lutz Institute, São Paulo, Brazil. The 
animals received water and food ad libitum and were kept in sterilized cages. The procedures 
involving animals were realized in agreement with the Guidelines for the Care and Use of Laboratory 
Animals from the National Academy of Sciences, USA. The project received ethical approval by the 
Research Ethics Commission of the Adolfo Lutz Institute/ Pasteur Institute (CEUA-IAL/Pasteur 02/2011), 
São Paulo, Brazil. 
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3.1. Compounds
The STLs investigated in this study were previously isolated in our laboratories (T.J.S., F.B.C.) from
plants of the family Asteraceae. Helenalin acetate (1) and mexicanin I (2) were isolated from A. montana
L. and Arnica acaulis (Walter) Britton, Sterns and Poggenb., respectively. The guaianolides arglabin (3)
and cynaropicrin (4) originate from Artemisia glabella Kar. Et Kir. Fl. Alt. and Cynara cardunculus L.,
respectively. Alantolactone (5) is an eudesmanolide isolated from Inula helenium L. The germacranolide
parthenolide (6) and the furanoheliangolide budlein A (7) were isolated from Tanacetum partheniu
(L.) Sch. Bip. and Aldama robusta (Gardner) E.E.Schill and Panero (formerly: Viguiera robusta).
Further details on the origin of these compounds and their purity were published previously [18,22,23].
In all cases, stock solutions were prepared with dimethyl sulfoxide (DMSO) which were subsequently
diluted with the respective medium to the specific concentration used in the various bioassays.
3.2. Animals
Golden hamsters (Mesocricetus auratus Waterhouse) were used for the maintenance of the
L. (L.) infantum (MHOM/BR/1972/LD) culture. Young female BALB/c mice (Mus musculus L.) with a
weight of 18–24 g were used as a source of peritoneal macrophages.
Animals were provided by the animal facility of the Adolfo Lutz Institute, São Paulo, Brazil.
The animals received water and food ad libitum and were kept in sterilized cages. The procedures
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involving animals were realized in agreement with the Guidelines for the Care and Use of Laboratory
Animals from the National Academy of Sciences, USA. The project received ethical approval by the
Research Ethics Commission of the Adolfo Lutz Institute/ Pasteur Institute (CEUA-IAL/Pasteur 02/2011),
São Paulo, Brazil.
3.3. Leishmania (Leishmania) infantum Promastigote, Peritoneal Macrophages, and NCTC Cells Culture
L. (L.) infantum (MHOM/BR/1972/LD) promastigotes were maintained in M-199 medium
supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco, Thermo Fisher Scientific,
São Paulo, Brazil), 0.25% hemin (Sigma-Aldrich), and 5% human urine at 24 ◦C. Amastigotes were
obtained from the spleen of previously infected hamsters by differential centrifugation. Macrophages
were collected from the peritoneal cavity of BALB/c mice by washing with RPMI-1640 medium
supplemented with 10% FBS, and were maintained at 37 ◦C in a 5% CO2-humidified incubator.
Murine fibroblasts NCTC (clone L929 ATCC) were used to evaluate the cytotoxicity of the tested
compounds. NCTC cells were maintained in M-199 medium supplemented with 10% FBS and
20 µg/mL gentamicin at 37 ◦C in a 5% CO2-humidified incubator.
3.4. Determination of 50% Inhibitory Concentration (IC50) against Leishmania and 50% Cytotoxicity
Concentration (CC50) against NCTC
3.4.1. Promastigotes
Compounds were dissolved in DMSO and diluted in M-199 medium in 96-well microplates,
with the highest concentration of 150 µM. Promastigotes of L. (L.) infantum in the late growth-phase
were seeded at 1 × 106/well and incubated with the compounds for 48 h. The viability of cells was
determined using the MTT assay [40]. An internal control group was used with 0.5% DMSO (maximal
concentration). Miltefosine was used as standard drug.
3.4.2. Intracellular Amastigotes of L. (L.) infantum
Murine peritoneal macrophages were collected from the peritoneal cavity of BALB/c mice, and
the macrophages were seeded at 1 × 105/well for 24 h in a 16-well slide. Amastigotes were prepared
(as described previously), seeded at a ratio 1:10 (macrophages:amastigotes) and kept at 37 ◦C in a 5%
CO2-humidified incubator for 24 h. Test compounds were incubated to the highest concentration of
100 µM with infected macrophages for 120 h. Miltefosine was used as a standard drug. Subsequently,
the cells were fixed with methanol, stained with Giemsa (Merck KGaA, Darmstadt, Germany), and
observed using a light microscope. The parasite burden was determined by the number of infected
macrophages out of 400 cells.
3.4.3. Cytotoxicity
NCTC cells were seeded at 6 × 104 in 96-well microplates and incubated with the compounds for
48 h. An internal control group was used with 0.5% DMSO (maximal concentration). The quantification
of viable cells was assessed by the MTT assay [40]. The selectivity index (SI) was determined using the
following equation: SI = CC50 in NCTC cells / IC50 against amastigotes.
3.5. Ultrastructural Analysis of Cellular Damage in Promastigotes Treated with Helenalin Acetate, Using TEM
Ultrastructural studies were performed with promastigotes treated with compound 1 by TEM.
L. (L.) infantum promastigotes in the late growth phase were washed and incubated with 120 µM of 1
(corresponding to the IC99 value obtained with 1× 106 parasites/well) at 2× 107/well in 200 µL M-199
medium. Compound incubation was performed for 0.5, 1, 2, 3, and 4 h under the previously described
growth conditions. After centrifugation at 2800 rpm for 10 min, the parasites were fixed with 1 mL
glutaraldehyde and the sample processing was performed according to Duarte et al. [41]. The TEM
imaging was performed on a JEOL 1011 transmission electron microscope (Peabody, MA, USA).
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3.6. Determination of Plasma Membrane Permeability in Helenalin Acetate-Treated Promastigotes
Late-growth-phase (non-stationary) promastigotes were incubated with the probe SYTOX Green
(Molecular Probes Inc., Eugene, OR, USA), as previously described [42]. Concentrations of 1 were
chosen in accordance with the respective IC50 and IC99 values. 1 was added at 3 and 6 µM to
1 × 106 cells/well, at 24 ◦C. The fluorescence was measured every 20 min (0–80 min). At the end of the
assay (80 min), 0.1% Triton X-100 was added to all wells to obtain the maximum permeabilization of
parasites. Fluorescence intensity was determined using a fluorimetric microplate reader (FilterMax F5
Multi-Mode Microplate Reader-Molecular Devices, Sunnyvale, CA, USA) with excitation and emission
wavelengths of 485 and 520 nm, respectively. The following internal controls were used during the
evaluation: (i) the background fluorescence of the compound at the respective wavelengths; (ii) the
possible interference of DMSO; (iii) untreated promastigotes; and (iv) medium without any cells.
Samples were tested in duplicate.
3.7. Determination of the Mitochondrial Membrane Potential (∆ψm) and ROS by Fluorescence-Activated
Cell Sorting
The ∆ψm and ROS content of promastigotes treated with compound 1 were determined using
the fluorescence probes rhodamine 123 and H2DCFDA (Molecular Probes Inc., Eugene, OR, USA),
respectively, and further evaluated by flow cytometry [25,43]. Briefly, 2 × 106 promastigotes/well
cultured until the late growth-phase were treated with 12 µM of 1 (corresponding to the IC99 value
obtained with 1 × 106 parasites/well). The parasites were incubated in HANKS’ balanced salts
solution (HBSS; Sigma-Aldrich, Carlsbad, CA, USA), supplemented with 10 mM D-Glucose, at 26 ◦C
for 1 h. Afterwards the parasites were washed and stained with rhodamine 123 (0.3 µg/mL) or
H2DCFDA (5 µM) for 15 min under absence of light. The washed parasites were resuspended in
PBS and the fluorescence was measured in a Flow Cytometer Attune Nxt (ThermoFisher Scientific,
Waltham, MA, USA) using the forward scatter (FSC, relative cell size) and the side scatter detectors
(SSC, cell granulometry or internal complexity), FL1-A (detecting fluorescence emission 530 ± 15 nm),
and Attune Nxt software. As control, untreated promastigotes (not stained with Rd123 or H2DCFDA)
served to monitor the basal fluorescence. FCCP (10 µM) and oligomycin (20 µM) provided information
on the maximal mitochondrial depolarization and maximal ROS production, respectively. Samples
were tested in duplicate. Two independent assays were performed.
3.8. Production of Nitric Oxide (NO) in Macrophages Treated with Helenalin Acetate
The NO production of macrophages treated with 1 was performed using the Griess assay [39].
Briefly, 1× 105/well peritoneal macrophages of BALB/c mice were seeded overnight in a 96-well plate.
Fresh medium containing compound 1 at 3 µM (corresponding to the CC25 value obtained with NCTC
cells) or 5 µg/mL LPS (positive control) were added and incubated for 24 h at 37 ◦C. Afterwards the
NO content of each of the cultures’ supernatant was analysed using the Griess assay. The samples’ NO
content was determined by means of a standard curve prepared with NaNO2 at concentrations from
0 to 400 µM.
3.9. Statistical Analysis
Data processing and statistical analyses was done with GraphPad Prism® 5.0 (GraphPad Software,
Inc. La Jolla, CA, USA). For determination of antileishmanial activity and NCTC cytotoxicity, the
IC50 and CC50 values were calculated after normalization using sigmoidal dose-response curves.
The evaluation of statistical significance of multiple pairs was done with a Tukey's range test, which
corrects for the increased probability of a type I error during multiple comparison.
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4. Conclusions
The present study revealed the in vitro anti-Leishmania (L.) infantum efficacy of seven STLs
isolated from plants of the Asteraceae family. Helenalin acetate (1) and mexicanin I (2) showed the
highest potency of all tested compounds and a certain selectivity against L. (L.) infantum intracellular
amastigotes. Helenalin acetate (1) affected mitochondria at an early phase during incubation, causing
depolarization of the mitochondrial membrane potential. These early events could be related to
altered ATP production, since the mitochondrion is a pivotal organelle for bioenergetic homeostasis.
Additionally, it was demonstrated that the activity of 1 against intracellular amastigotes could be,
at least in part, related to an increased NO-production of the host cells since an elevated release of
NO was induced by the compound in peritoneal macrophages. Helenalin acetate and, possibly, other
STLs such as mexicanin I, may thus represent interesting scaffolds for the synthesis of derivatives with
potent and selective activity against L. (L.) infantum.
Supplementary Materials: Supplementary materials are available online. Figure S1: Helenalin acetate activity
against intracellular L. (L.) infantum amastigotes (GIEMSA-stained light microscopy images).
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